Clinical Trials Browser

Phase 1/2 × NIH × Daclizumab × Clear all

NCT00019227 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Leukemia

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma